Medidata and ICON Join Forces to Bring New Productivity to Capturing Patient Voice in Clinical Trials
10 Septembre 2014 - 2:52PM
Business Wire
Joint ePRO Initiative Delivers Ready-to-Use,
Patient-Centric Solutions to Speed Trial Times and Enhance Patient
Engagement
Medidata (NASDAQ:MDSO), the leading global provider of
cloud-based solutions for clinical research in life sciences, and
ICON plc, (NASDAQ:ICLR) a global provider of outsourced development
services to the pharmaceutical, biotechnology and medical device
industries, today announced a joint initiative designed to bring
new efficiencies to the administration of electronic
patient-reported outcomes (ePROs) in clinical trials. By combining
Medidata’s best-in-class technology with ICON’s ready-to-use,
pre-validated surveys, the new offering provides sponsors with an
ePRO solution that reduces costs, saves time and enhances patient
engagement.
Medidata Patient Cloud™, an innovative ePRO solution for
patient-centric data capture, significantly simplifies trial setup
through its configurable interface with the Medidata Clinical
Cloud™. ICON brings ready-to-go, pre-validated patient input
instruments for fast clinical trial deployment. These productivity
enhancements, combined with the Patient Cloud interface available
as a mobile app, create an industry-leading solution for capturing
patient input in clinical research.
“We are pleased to extend our partnership with Medidata,”
commented Dermot Kenny, Executive Vice President, Global Clinical
and Data Operations. “Their innovative technology, together with
ICON’s market-leading expertise, creates a solution that will help
customers reduce study timelines and makes it easier for patients
to record their experiences.”
Available on any iOS® device and automatically unified with
Medidata’s platform, Patient Cloud provides electronic patient
questionnaire and diary functionality in a model that simplifies
the setup process, freeing research organizations from the burdens
of custom software and proprietary devices. And in simplifying the
data capture and patient participation processes, Medidata’s ePRO
solution is transforming the clinical trial experience for study
participants at a time when capturing the patient voice is becoming
increasingly important.
“We’re thrilled to be expanding this partnership and share
ICON’s commitment to bringing the voice of the patient to clinical
research,” said Glen de Vries, Medidata’s president. “Together,
we’re changing how the industry conducts clinical trials by making
ePROs applicable to a wider array of studies, reducing the work
required to use them and eliminating pain points such as
equivalencies and other complicated processes.”
Connect with Medidata:
- Read our blog, Geeks Talk Clinical
- Tweet this: .@Medidata and @ICONplc
partner to take ePRO to new places, helping to capture the #patient
voice in #clinicaltrials http://bit.ly/1rAZ5Rn
- Follow us on Twitter: @Medidata
- Find us on LinkedIn
About ICON plc
ICON plc is a global provider of outsourced development services
to the pharmaceutical, biotechnology and medical device industries.
The company specialises in the strategic development, management
and analysis of programs that support clinical development - from
compound selection to Phase I-IV clinical studies. ICON currently
has approximately 11,000 employees, operating in 38 countries.
Further information is available at www.iconplc.com.
About Medidata Solutions
Medidata is the leading global provider of cloud-based solutions
for clinical research in life sciences, transforming clinical
development through its advanced applications and intelligent data
analytics. The Medidata Clinical Cloud™ brings new levels of
productivity and quality to the clinical testing of promising
medical treatments, from study design and planning through
execution, management and reporting. We are committed to advancing
the competitive and scientific goals of global clients, which
include over 90% of the top 25 global pharmaceutical companies;
innovative biotech, diagnostic and device firms; leading academic
medical centers; and contract research organizations.
Media:Medidata SolutionsGail Janowitz,
212-918-1792gjanowitz@mdsol.comorICON PlcWeber ShandwickRebecca
Power, 44 (0) 207-067-0866RPower@webershandwick.com
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Août 2023 à Août 2024